Kuivanen, Suvi <br/><br/>
Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.  [electronic resource] 

 -  Antiviral research  Mar 2017 
 - 117-128 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-9096 
<br/><br/><label>Standard No.: </label>10.1016/j.antiviral.2016.12.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--pharmacology<br/>Antiviral Agents--pharmacology<br/>Brain--cytology<br/>Caspases--metabolism<br/>Deoxycytidine--analogs & derivatives<br/>Drug Combinations<br/>Enzyme Inhibitors--pharmacology<br/>Fetus--anatomy & histology<br/>Humans<br/>Indoles<br/>Metabolic Networks and Pathways--drug effects<br/>Pyrroles--pharmacology<br/>RNA, Viral--metabolism<br/>Retinal Pigment Epithelium--cytology<br/>Salicylates--pharmacology<br/>Signal Transduction--drug effects<br/>Virus Replication--drug effects<br/>Zika Virus--drug effects<br/>Gemcitabine